Elena Ridloff - Mar 12, 2021 Form 4/A - Amendment Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Mar 12, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/15/2022, 04:15 PM
Date Of Original Report
Mar 16, 2021
Next filing
Apr 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Award $0 +20.9K $0.00 20.9K Mar 12, 2021 Common Stock 20.9K $56.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on March 12, 2021.

Remarks:

This Amended Form 4 restates the original Form 4 in its entirety.